Skip to content
  • Sunday, 26 July 2026
  • 1:47 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Navigating the Evolving Landscape of Oral Solid Dosage Development: A Framework for Enhanced Efficiency and Commercial Success
Pharmaceutical R&D

Navigating the Evolving Landscape of Oral Solid Dosage Development: A Framework for Enhanced Efficiency and Commercial Success

Teuku Ryan May 7, 2026 0

The pharmaceutical industry is witnessing a significant evolution in oral solid dosage (OSD) development, driven by an increasing demand for…

Read More
Pharmaceutical R&D

Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach

Teuku Ryan Apr 9, 2026 0

Everest Medicines, a leading biopharmaceutical company focused on developing and commercializing innovative medicines for chronic diseases, has announced a significant…

Read More
Pharmaceutical R&D

The UK Must Supercharge Its Commercial Strategy to Boost Global Life Sciences Competitiveness

Teuku Ryan Apr 1, 2026 0

Off the northwestern coast of mainland Europe, an island nation with significant ambitions for its life sciences sector is navigating…

Read More
Pharmaceutical R&D

Europe’s Biopharmaceutical Competitiveness and Commercial Strategies Under Scrutiny at BIO Europe Spring

Teuku Ryan Mar 28, 2026 0

Lisbon, Portugal – As the vibrant city of Lisbon recently concluded its tenure as host for the annual BIO Europe…

Read More
A Weird Force That Skirts Traditional Physics Norms Has Helped Erase a Smudge on the Foundations of Particle PhysicsThe Benefits of Moderate Caffeine Consumption for Long-Term Cognitive Health and Dementia PreventionA New Vaccine Adjuvant Could Revolutionize Polio Eradication by Inducing Robust Mucosal ImmunityThe Discovery Deepens a Mystery Over How Black Holes Grew So Big So Early in the Universe
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ